B
Bryan Burmeister
Researcher at Princess Alexandra Hospital
Publications - 163
Citations - 8693
Bryan Burmeister is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 39, co-authored 158 publications receiving 7908 citations. Previous affiliations of Bryan Burmeister include Sir Charles Gairdner Hospital & University of Queensland.
Papers
More filters
Journal ArticleDOI
Adjuvant radiotherapy after lymphadenectomy in melanoma patients: Final results of an intergroup randomized trial (ANZMTG 0.1.02/TROG 02.01).
Michael A. Henderson,Bryan Burmeister,Jill Ainslie,Richard Fisher,Julianna Di Iulio,Bernard Mark Smithers,Angela Hong,Kerwin F. Shannon,Richard A. Scolyer,Scott Carruthers,Brendon J. Coventry,Scott Babington,João Pedreira Duprat,Harald J. Hoekstra,John F. Thompson +14 more
TL;DR: This final report of a multicenter randomized trial updates survival and lymph node field (LNF) control, and reports long term treatment toxicity, lymphedema and quality of life (QOL) (Lancet Oncol 2012).
Journal ArticleDOI
P2-162: Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non small cell lung cancer (“CRITICAL”)
David Ball,Bryan Burmeister,Paul Mitchell,Michael Boyer,Michael P. Mac Manus,Euan Walpole,M. Feigen,Mo Mo Tin,Danny ischin +8 more
Journal ArticleDOI
Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.
Gerald B Fogarty,Angela Hong,Kari Dolven Jacobsen,Claudius H Reisse,Brindha Shivalingam,Bryan Burmeister,Lauren E. Haydu,Elizabeth Paton,John F. Thompson +8 more
TL;DR: Despite only 54 patients and not the full 60 patient target being accrued in two years the Trial Management Committee and Data Safely Monitoring Committee approved the continuation of the pilot study to the main trial and funding was achieved for the full study.
Journal ArticleDOI
Hypofractionated radiotherapy for complicated bone metastases in patients with poor performance status: a phase II international trial:
Mauricio F. Silva,Gustavo Nader Marta,Felipe P C Lisboa,Guilherme Watte,Fabio Trippa,Ernesto Maranzano,Neiro Waechter da Motta,Marko Popovic,Tuan Ha,Bryan Burmeister,Edward Chow +10 more
TL;DR: Hypofractionated radiotherapy (16 Gy in 2 fractions of 8 Gy 1 week apart) achieved satisfactory pain relief and safety results in patients with complicated bone metastases and poor performance status.
Journal ArticleDOI
Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
Samantha Barbour,B. Mark Smithers,Christopher Paul Allan,Gerard Bayley,Janine Thomas,Matthew Foote,Bryan Burmeister,Andrew Barbour +7 more
TL;DR: Using a selective approach for adjuvant RT, isolated cervical recurrence after TLND is uncommon and can be salvaged effectively with further local therapy; however, distant disease frequently follows.